University of Queensland Centre for Clinical Research, Royal Brisbane and Woman's Hospital, Herston, Queensland, Australia.
Department of Infectious Diseases, Mater Hospital Brisbane, South Brisbane, Queensland, Australia.
J Clin Microbiol. 2021 Jun 18;59(7):e0042421. doi: 10.1128/JCM.00424-21.
Burkholderia pseudomallei is a tier 1 select agent that is associated with laboratory-acquired melioidosis, with international guidelines recommending isolate handling within a class II biosafety cabinet (BSC) in a biosafety level 3 (BSL3) facility. In low-resource settings, this may not be practical; therefore, we aimed to assess the risk of laboratory-acquired melioidosis during routine work. Prior exposure to the organism was determined with a questionnaire and concomitant serology. Of 30 laboratory scientists handling B. pseudomallei on 1,267 occasions outside a biosafety cabinet, no infections were documented and all participants remained seronegative. Additionally, we performed controlled environmental air sampling during 78 laboratory handling events, including plate opening, oxidase testing, and McFarland suspension creation. None of the experiments demonstrated aerosolization of the organism. This study suggests the risk of laboratory-acquired melioidosis is low. However, individual laboratories will need to undertake a risk assessment, including melioidosis endemicity, availability of resources for containment, the nature of routine handling to be undertaken, and the presence of predisposing risk factors for infection in the staff concerned. Additionally, laboratories should take region-specific guidelines into consideration. Further research is required to better inform on the overall risk of infection in the microbiology laboratory.
类鼻疽伯克霍尔德菌是一种一级选择剂,与实验室获得性类鼻疽病有关,国际指南建议在三级生物安全设施(BSL3)的二级生物安全柜(BSC)中进行分离物处理。在资源匮乏的环境中,这可能不切实际;因此,我们旨在评估常规工作中实验室获得性类鼻疽病的风险。通过问卷调查和同时进行的血清学检查来确定先前是否接触过该生物体。在没有生物安全柜的情况下,有 30 名实验室科学家对 1267 次类鼻疽伯克霍尔德菌进行了处理,没有记录到感染,并且所有参与者的血清学均为阴性。此外,我们在 78 次实验室处理事件(包括平板开盖、氧化酶检测和麦氏比浊管悬液制备)期间进行了受控环境空气采样。没有一项实验显示该生物体发生了气溶胶化。本研究表明,实验室获得性类鼻疽病的风险较低。然而,各个实验室需要进行风险评估,包括类鼻疽病的流行程度、遏制资源的可用性、将要进行的常规处理的性质以及有关工作人员感染的潜在危险因素的存在。此外,实验室应考虑特定区域的指南。需要进一步的研究来更好地了解微生物学实验室中感染的总体风险。